Previous 10 | Next 10 |
Health and wellness company makes $20 million capital commitment to LifeMD, enters medically supported weight loss market projected to reach up to $100 billion by 2030 Company discontinues quarterly cash dividend and intends to invest in initiatives aimed at driving customer acquisition a...
2023-11-24 05:46:27 ET Summary Medifast has strong financials with a healthy cash position and no debt, but its sales have plummeted, and its business model is questionable. MED's efficiency and profitability metrics are impressive, but its high-priced products may deter customers...
2023-11-19 10:14:12 ET Summary Dividend growth stocks often provide reliable cash flows and long-term wealth for income investors. Screening dividend stocks based on safety, growth, and consistency can be beneficial to find new opportunities important for investors. In this mo...
2023-11-18 08:00:00 ET Summary The consumer staples sector is very close to 11-year averages in valuation. The tobacco industry has the best value score, but quality metrics are underwhelming. iShares US Consumer Staples ETF has been outperforming XLP since inception. ...
2023-11-09 08:40:22 ET Summary Medifast, Inc. stock is down 80% from its mid-2021 peak, and from a valuation perspective, it looks like a veritable deep-value opportunity. Medifast is currently facing challenges due to elevated consumer price inflation, but increasingly also due t...
2023-11-06 18:50:27 ET Medifast, Inc. (MED) Q3 2023 Earnings Conference Call November 06, 2023, 04:30 PM ET Company Participants Steven Zenker - Vice President of Investor Relations Dan Chard - Chairman and Chief Executive Officer Jim Maloney - Chief Financial Of...
2023-11-06 16:07:28 ET More on Medifast Medifast: The Race To Weight-Loss Drugs Not Lost Yet Seeking Alpha’s Quant Rating on Medifast Historical earnings data for Medifast Dividend scorecard for Medifast Financial information for Medifast ...
Medifast (NYSE: MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTA VIA® , today reported results for the third quarter ended September 30, 2023. Third Quarter 2023 Revenue of $235.9 million, with revenue per activ...
CGG ADR (CGGYY) is expected to report for quarter end 2023-09-30 ATI Physical Therapy Inc. Class A (ATIP) is expected to report $-4.08 for Q3 2023 Riot Platforms Inc. (RIOT) is expected to report $-0.29 for Q3 2023 Bain Capital Specialty Finance Inc. (BCSF) is expected to report $0.57...
MEDIFAST INC (MED) is expected to report $1.02 for Q3 2023
News, Short Squeeze, Breakout and More Instantly...
Medifast (NYSE: MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTA VIA®, will announce financial results for the second quarter ended June 30, 2024 on Monday, August 5, 2024, after market close. The Company will host a conferen...
2024-07-03 02:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...